Prognostic significance and molecular associations of CDKN2A (p16) promoter methylation and loss of expression in colorectal cancer

被引：0
|
作者：
Shima, Kaori
Nosho, Katsuhiko
Baba, Yoshifumi
Cantor, Mami
Giovannucci, Edward L.
Fuchs, Charles S.
Ogino, Shuji
机构：
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/1538-7445.AM10-4639
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4639
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Methylation: A major cause of p16/CDKN2A inactivation in uveal melanoma
    Metzelaar, JW
    van der Velden, PA
    Gruis, NA
    Hurks, HM
    Ksander, BR
    Jager, MJ
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S184 - S184
  • [22] Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas
    Tang, Vivian
    Lu, Rufei
    Mirchia, Kanish
    Van Ziffle, Jessica
    Devine, Patrick
    Lee, Julieann
    Phillips, Joanna J. J.
    Perry, Arie
    Raleigh, David R. R.
    Lucas, Calixto-Hope G.
    Solomon, David A. A.
    ACTA NEUROPATHOLOGICA, 2023, 145 (04) : 497 - 500
  • [23] Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas
    Vivian Tang
    Rufei Lu
    Kanish Mirchia
    Jessica Van Ziffle
    Patrick Devine
    Julieann Lee
    Joanna J. Phillips
    Arie Perry
    David R. Raleigh
    Calixto-Hope G. Lucas
    David A. Solomon
    Acta Neuropathologica, 2023, 145 : 497 - 500
  • [24] Mutations, methylation and expression of CDKN2α/p16 gene in colorectal cancer and normal colonic mucosa
    Trzeciak, L
    Hennig, E
    Kolodziejski, J
    Nowacki, M
    Ostrowski, J
    CANCER LETTERS, 2001, 163 (01) : 17 - 23
  • [25] Molecular detection of p16 promoter methylation in the serum of recurrent colorectal cancer patients
    Nakayama, H
    Hibi, K
    Takase, T
    Yamazaki, T
    Kasai, Y
    Ito, K
    Akiyama, S
    Nakao, A
    INTERNATIONAL JOURNAL OF CANCER, 2003, 105 (04) : 491 - 493
  • [26] Usefulness of molecular detection of p16 promoter methylation in the serum of patients with colorectal cancer
    Adachi, M
    Iinuma, H
    Yago, H
    Arai, T
    Omi, T
    Haku, EK
    Nozawa, K
    Matsuda, K
    Mimura, T
    Kodaira, S
    Okinaga, K
    DISEASES OF THE COLON & RECTUM, 2004, 47 (06) : 967 - 968
  • [27] Usefulness of molecular detection of P16 promoter methylation in the serum of patients with colorectal cancer
    Adachi, M
    Iinuma, H
    Yago, H
    Arai, T
    Omi, T
    Haku, EK
    Nozawa, K
    Matsuda, K
    Mimura, T
    Kodaira, S
    Okinaga, K
    PROCEEDINGS OF THE XXTH BIENNIAL CONGRESS OF THE INTERNATIONAL SOCIETY OF UNIVERSITY COLON AND RECTAL SURGEONS, 2004, : 217 - 221
  • [28] MTAP and p16 IHC as Markers for CDKN2A/B Loss in Meningiomas
    Ozkizilkaya, Hanim I.
    Vinocha, Anjali
    Dono, Antonio
    Ogunbona, Oluwaseun Basit
    Toruner, Gokce A.
    Aung, Phyu P.
    Kamiya Matsuoka, Carlos
    Esquenazi, Yoshua
    Demonte, Franco
    Ballester, Leomar Y.
    CANCERS, 2024, 16 (19)
  • [29] MTAP and p16 Immunohistochemistry as Markers for CDKN2A/B Loss in Meningiomas
    Ozkizilkaya, H.
    Ozkizilkaya, H.
    Ogunbona, O. Basit
    Toruner, G.
    Aung, P.
    Esquenazi, Y.
    DeMonte, F.
    Ballester, L.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2023, 82 (06): : 546 - 546
  • [30] A common variant of CDKN2A (p16) predisposes to breast cancer
    Debniak, T
    Górski, B
    Huzarski, T
    Byrski, T
    Cybulski, C
    Mackiewicz, A
    Gozdecka-Grodecka, S
    Gronwald, J
    Kowalska, E
    Haus, O
    Grzybowska, E
    Stawicka, M
    Swiec, M
    Urbanski, K
    Niepsuj, S
    Wasko, B
    Gózdz, S
    Wandzel, P
    Szczylik, C
    Surdyka, D
    Rozmiarek, A
    Zambrano, O
    Posmyk, M
    Narod, SA
    Lubinski, J
    JOURNAL OF MEDICAL GENETICS, 2005, 42 (10) : 763 - 765
12345